Central Drug Standards And Control Organization
-
{
- All
- News
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
India's Reaction To Report On Johnson And Johnson Baby Powder
India's drug regulator said on Tuesday a news agency Reuters report that Johnson & Johnson knew for decades that cancer-causing asbestos lurked in its baby powder was "under consideration".
-
Pharma Firms Can Now Export Medicines, Devices Without 'No Objection Certificate'
To ensure ease of doing business, the Central Drugs Standard Control Organization (CDSCO) has waived the provision of procuring "no-objection" certificate (NOC) by pharmaceutical companies for exporting drugs, medical devices and cosmetics across ports in the country.
-
Medications Such As Combiflam, D Cold Total And Others Found To Be 'Substandard'
The Central Drugs Standard Control Organization, which regulates the sale and distribution drugs in India, has reportedly found popular medication like Combiflam, a pain reliever, and D Cold Total, a cold medicine, to be substandard.
_636284032999270124.jpg?downsize=260:195 "Medications Such As Combiflam, D Cold Total And Others Found To Be 'Substandard'")
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
India's Reaction To Report On Johnson And Johnson Baby Powder
India's drug regulator said on Tuesday a news agency Reuters report that Johnson & Johnson knew for decades that cancer-causing asbestos lurked in its baby powder was "under consideration".
-
Pharma Firms Can Now Export Medicines, Devices Without 'No Objection Certificate'
To ensure ease of doing business, the Central Drugs Standard Control Organization (CDSCO) has waived the provision of procuring "no-objection" certificate (NOC) by pharmaceutical companies for exporting drugs, medical devices and cosmetics across ports in the country.
-
Medications Such As Combiflam, D Cold Total And Others Found To Be 'Substandard'
The Central Drugs Standard Control Organization, which regulates the sale and distribution drugs in India, has reportedly found popular medication like Combiflam, a pain reliever, and D Cold Total, a cold medicine, to be substandard.
